CELL - AND EXOSOME - BASED LIQUID BIOPSY

Cell- and exosome-based liquid biopsy is now here. As a liquid biopsy company, BioFluidica has created the future of liquid biopsy by creating LiquidScan^®. *LiquidScan isolates rare cells and exosomes, making diagnostics possible for cell- and exosome-based liquid biopsy.

*LiquidScan combines cutting-edge microfluidics, advanced immunoaffinity chemistries, automation hardware, and workflow optimization to put liquid biopsy within easier reach for precision medicine for multiple cancers and prenatal diagnostics testing.